本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Standard BioTools Inc.

1.08
+0.02001.89%
盤後1.080.00000.00%18:08 EDT
成交量:117.10萬
成交額:125.50萬
市值:4.10億
市盈率:-3.04
高:1.09
開:1.07
低:1.04
收:1.06
資料載入中...
2024/01/13

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/10

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/10

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/08

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/05

重要事件披露

Form 8-K - Current report
2023/12/30

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/12/30

重要事件披露

Form 8-K - Current report
2023/12/26

重要事件披露

Form 8-K - Current report
2023/12/26

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/12/20

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/12/20

重要事件披露

Form 8-K - Current report
2023/12/04

重要事件披露

Form 8-K - Current report
2023/12/04

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/12/01

SEC問詢函

Form CORRESP - Correspondence
2023/11/29

重要事件披露

Form 8-K - Current report
2023/11/29

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/11/23

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/22

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/11/22

重要事件披露

Form 8-K - Current report